In a recent research report by Maximize Market Research, the COVID-19 Vaccine Development Tools Market is expected to surpass the US $ 31.0 Billion by the year 2027, from the US $ 17.5 Billion in 2020.
AI (Artificial intelligence) has tremendous potential to speed up and transform the development of new COVID-19 vaccines. AI is expected to perform a key role in the development of vaccines for new coronavirus strains, and companies in this sector are working with vaccine manufactures to expand the market. Nanotronics, announced in April 2021, that it has collaborated with a no. of important COVID-19 vaccine developers to help with the effective management of data relevant to COVID-19 vaccine research projects using AI-based online tools.
Online technologies are expected to expand at a quick rate with a CAGR of 13.2% in the forecast period. Apart from the increased need for vaccination management and tracking systems, existing companies are also pursuing the use of interactive online platforms that aid in R&D. COVID-19 Vaccine Predictor, a web tool, was introduced in November 2021. This web tool allows users to understand the newly updated vaccination portfolio as well as create R&D operation timeline forecasts.
Pharma and biopharma businesses led the market in 2021, representing nearly 42.0 % sales. Due to their existing vaccine development infrastructure, these businesses were among the first to begin investigations on SARS-CoV-2 in the early phases of the epidemic. For example, in January 2021, Merck Research Labs researchers gathered previously known knowledge of coronavirus and began identifying prospective methods for vaccines and medicines development with potential efficacy against SARS-CoV-2. The organization looked at about 1,000 chemicals from its enormous library to see how effective they were against SARS-CoV2
In 2020, Asia Pacific led the COVID-19 vaccine development tools market, accounting for 39.6% of total revenue. The early discovery of the new coronavirus’ genome utilizing sophisticated sequencing techniques in the region was a key role in the expedited vaccine development for SARS-CoV-2. Researchers in China used next-generation sequencing, electron microscopy, and flow cytometry to undertake various investigations focused on early genome sequencing, viral structural analysis, and immune response profiling
Despite a huge decline in the sales of Applications during the initial phase of pandemic spread and lockdown restrictions all over the region, the market is observed to pick up a quick pace for registering a CAGR of almost more than 8.7%, during the tenure of 2021 – 2027.
The report published by Maximize encompasses the market dynamics, which could affect the market growth of Contrast-Enhanced Ultrasound in the region, the Value – Chain Analysis, and the PORTER’s analysis for the Contrast-Enhanced Ultrasound market at a global level
The study is associated based on major segments and further into sub-segments By Technology (Laboratory Technologies, Online Technologies), Application (Vaccine Research, Vaccine Process Development, Vaccine Quality Assurance/Quality Control), End-Users (Pharma & Biopharma Companies, Contract Research Organization (CROs), Academic & Research Institutes), to forecast the market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the market research report provides a regional comparison and a complete country-level analysis for the Application trends, along with the major key players- Thermo Fisher Scientific, Inc.; Celerion; Cole-Parmer Instrument Company, LLC.; Pfizer Inc.; Sartorius AGSTEMCELL Technologies Inc.; AB Sciex Pte. Ltd.; Illumina, Inc.; AgilentTechnologies; Bio-Rad Laboratories, Inc.; Danaher; Merck KGaA; Qiagen N.V.Shimadzu Corporation; Eurofins Scientific; Charles River Laboratories; Takara Bio Inc.; PerkinElmer Inc.
Fluidigm; OLYMPUS CORPORATION; Avantor, Inc. Polyplus Transfection; Hamilton Company; Aurora Biomed Inc.
You can browse the market data Tables and Figures spread through a comprehensive research report and in-depth TOC on “Global COVID-19 Vaccine Development Tools Market.”
Contact:
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Office no. 18.4,
Navale IT Zone Phase-2,
Mumbai -Bangalore bypass highway,
Pune- 18.411018.41
Maharashtra, India
+91 9607195908